Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

229.39
+0.75610.33%
Post-market: 230.310.9178+0.40%19:30 EDT
Volume:3K
Turnover:654.13K
Market Cap:464.86M
PE:- -
High:230.31
Open:229.91
Low:229.39
Close:228.64
52wk High:244.35
52wk Low:160.91
Shares:2.03M
Float Shares:2.03M
Volume Ratio:0.25
T/O Rate:0.14%
Dividend:0.96
Dividend Rate:0.42%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Yesterday

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Yesterday

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Yesterday

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Yesterday

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Yesterday

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million

Reuters
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10

Revolution Medicines to Gain From Drug Expansion, New Combination Therapies, Morgan Stanley Says

MT Newswires Live
·
Sep 10

Revolution Medicines, Inc. : Morgan Stanley Initiates Coverage with Overweight Rating; Price Target $255

THOMSON REUTERS
·
Sep 10

BeOne Medicines FY26 H1 Net Income Climbs to Us$464.36 Million; Revenue Rises 32.3% to Us$3.22 Billion

Reuters
·
Sep 10

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Amgen to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 10

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Sep 09